Concepedia

Daniel Lamarre

DL

64

Publications

5.8K

Citations

42

H-Index

1986

Active since

Affiliations

Boehringer Ingelheim (Canada)(Current)

Université de Montréal

Institute for Research in Immunology and Cancer

Boehringer Ingelheim (Germany)

Boehringer Ingelheim (Egypt)

Daniel Lamarre is an author at Boehringer Ingelheim (Canada) specializing in medicine, immunology, and molecular biology.

ORCID

Top concepts

Publications per year

1986–2020

64

Publications

64

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

Daniel Lamarre, Paul C. Anderson, Murray D. Bailey et al. · Nature · 2003 · 911 citations

, , +9

Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors

Louise Doyon, G Croteau, Diane Thibeault et al. · Journal of Virology · 1996 · 296 citations · Full text

, , +18

Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors

G Croteau, Louise Doyon, Diane Thibeault et al. · Journal of Virology · 1997 · 254 citations · Full text

, , +18

Modulation of chromatin superstructure induced by poly(ADP-ribose) synthesis and degradation.

Gilbert de Murcia, Ann Huletsky, Daniel Lamarre et al. · Journal of Biological Chemistry · 1986 · 196 citations · Full text

, , +16

Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infection

Youla S. Tsantrizos, Gordon T. Bolger, Pierre Bonneau et al. · Angewandte Chemie International Edition · 2003 · 188 citations

, , +17

Rows per page

1–5 of 64